{"id":"antimalarial-monoclonal-antibodies","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2109418","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"These antibodies are designed to bind to specific antigens expressed by Plasmodium parasites or their mosquito vectors, blocking parasite development, transmission, or invasion of host cells. By leveraging the immune system's antibody-mediated mechanisms, they aim to provide protection against malaria infection and reduce transmission potential.","oneSentence":"Monoclonal antibodies that target and neutralize malaria parasites or parasite-derived antigens to prevent infection and reduce disease severity.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:01:56.044Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Malaria prevention and treatment (investigational)"}]},"trialDetails":[{"nctId":"NCT01729455","phase":"","title":"Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-02-21","conditions":"Systemic Lupus Erythematosus","enrollment":3138},{"nctId":"NCT06076837","phase":"PHASE1","title":"The Seven Trial: Exploiting the Unfolded Protein Response","status":"ACTIVE_NOT_RECRUITING","sponsor":"HonorHealth Research Institute","startDate":"2025-01-09","conditions":"Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic","enrollment":6},{"nctId":"NCT05843188","phase":"PHASE2","title":"Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2023-08-09","conditions":"Metastatic Colorectal Cancer","enrollment":155},{"nctId":"NCT07021495","phase":"","title":"SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-07-29","conditions":"Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO)","enrollment":840},{"nctId":"NCT07082205","phase":"PHASE3","title":"Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital Discharge","status":"RECRUITING","sponsor":"Liverpool School of Tropical Medicine","startDate":"2025-05-02","conditions":"Malaria, Severe Malaria, Severe Anaemia","enrollment":398},{"nctId":"NCT03312907","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-03-01","conditions":"Systemic Lupus Erythematosus","enrollment":292},{"nctId":"NCT04726553","phase":"EARLY_PHASE1","title":"Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE","status":"UNKNOWN","sponsor":"Oklahoma Medical Research Foundation","startDate":"2021-01-20","conditions":"Systemic Lupus Erythematosus (SLE)","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":246,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["L9LS"],"phase":"phase_3","status":"active","brandName":"Antimalarial monoclonal antibodies","genericName":"Antimalarial monoclonal antibodies","companyName":"Liverpool School of Tropical Medicine","companyId":"liverpool-school-of-tropical-medicine","modality":"Biologic","firstApprovalDate":"","aiSummary":"Monoclonal antibodies that target and neutralize malaria parasites or parasite-derived antigens to prevent infection and reduce disease severity. Used for Malaria prevention and treatment (investigational).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}